Phase II trial with docetaxel in patients with relapsing germ cell cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel (Primary)
- Indications Germ cell and embryonal neoplasms
- Focus Therapeutic Use
- 02 Jul 2012 Biomarkers information updated
- 29 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2005 New trial record.